Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Biota licenses compounds for the treatment of prostate cancer

May 14, 1997

In vivo growth arrest of mammary carcinoma by ibuprofen

May 14, 1997

In vivo and clinical antitumor activity of recombinant methioninase

May 14, 1997

Lilly synthesizes antifolates that potently inhibit human DHFR

May 14, 1997

Clinical results for Zambon's N-acetylcysteine as chemopreventive agent

May 14, 1997

Clinical results for titanocene dichloride in solid tumors

May 14, 1997

In vivo and in vitro characterization of the novel vinca alkaloid F-12158

May 14, 1997

In vivo profile of AMD-473

May 14, 1997

IL-18 evaluated for biological and antitumor activity

May 13, 1997

Preliminary phase I results for dolastatin 10 in advanced solid tumors

May 13, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 19, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 19, 2025.
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
ABS-1230 controls seizures in KCNT1-driven severe epilepsy
BioWorld Science
Mutations in the KCNT1 gene produce gain-of-function effects that lead to overactivation of the potassium channel and consequent disruption of normal neuronal...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.